ArticleChildren (Basel, Switzerland)2019
Management of Congenital Heart Disease: State of the Art; Part I-ACYANOTIC Heart Defects.
Article in Children (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 51 citations in OpenAlex.
- Anaesthetic management and clinical outcomes of balloon pulmonary valvuloplasty in dogs with severe pulmonic stenosis: a retrospective study (2024-2025).Frontiers in veterinary science · 2026Article
- Differences in the EarlyJournal of cardiovascular development and disease · 2025Article
- Development and validation of a prognostic risk model for pediatric patients with left-to-right shunt congenital heart disease and heart failure.Frontiers in public health · 2025Article
- Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review.Paediatric drugs · 2024Article
- Interventional heart catheterization to close atrial septal defect, patent ductus arteriosus, ventricular septal defect in a 3.5-year-old girl; a case report study.Journal of surgical case reports · 2024Article
- HomozygousJournal of medical genetics · 2024Article
- SMAD6-deficiency in human genetic disorders.NPJ genomic medicine · 2022Review
- Interventions in Adults With Repaired Coarctation of the Aorta.Journal of the American Heart Association · 2022Article
- Does Oxygen Content Play a Role in Spontaneous Closure of Perimembranous Ventricular Septal Defects?Children (Basel, Switzerland) · 2021Article
- Outcomes of Device Closure of Atrial Septal Defects.Children (Basel, Switzerland) · 2020Review
- Management of Congenital Heart Disease: State of the Art-Part II-Cyanotic Heart Defects.Children (Basel, Switzerland) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the description of surgery for patent ductus arteriosus in late 1930s, an innumerable number of advances have taken place in the management of congenital heart defects (CHDs). In this review the current status of treatment of seven of the most common acyanotic CHDs was reviewed. The discussion included indications for, and timing of, intervention and methods of intervention. The indications are, by and large, determined by the severity of the lesion. Pressure gradients in obstructive lesions and the magnitude of the shunt in left-to-right shunt lesions are used to assess the severity of the lesion. The timing of intervention is different for each lesion and largely dependent upon when the criteria for indications for intervention were met. Appropriate medical management is necessary in most patients. Trans-catheter methods are preferable in some defects while surgery is a better option in some other defects. The currently available medical, trans-catheter, and surgical methods to treat acyanotic CHD are feasible, safe, and effective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.